Clostridium sordellii infections pose difficult clinical challenges and are usually fatal. Most commonly, these infections occur after trauma, childbirth, and routine gynecological procedures, but they have recently been associated with medically induced abortions and injection drug use. We report 2 fatal cases, one of which was associated with minor trauma, and the other of which was associated with normal childbirth, and we summarize the clinical features of 43 additional cases of reported C. sordellii infection. Of these 45 cases, 8 (18%) were associated with normal childbirth, 5 (11%) were associated with medically induced abortion, and 2 (0.4%) were associated with spontaneous abortion. The case-fatality rate was 100% in these groups. Ten (22%) of the C. sordellii infections occurred in injection drug users, and 50% of these patients died. Other cases of C. sordellii infection (in 19 patients [43%]) occurred after trauma or surgery, mostly in healthy persons, and 53% these patients died. Overall, the mortality rate was 69% (31 of 45 patients). Eighty-five percent of all patients with fatal cases died within 2-6 days of initial infection, and nearly 80% of fatal cases developed leukemoid reactions. Rapid diagnostic tests and improved treatments are needed to reduced the morbidity and mortality associated with this devastating infection.
INTRODUCTION, HISTORICAL PERSPECTIVE, MICROBIOLOGY
Clostridium sordellii was first isolated in 1922 by the Argentinean microbiologist Alfredo Sordelli [1] , who named it Bacillus oedematis sporogenes on the basis of its morphology and the marked tissue edema characteristic of infection. In 1927, the organism was renamed Bacillus sordellii [2] . Two years later, it was shown to be identical to Clostridium oedematoides [3, 4] , and the name C. sordellii was adopted. Similarities in morphology and biochemical profile suggested that C. sordellii was simply a virulent strain of Clostridium bifer- 
ILLUSTRATIVE CASE REPORTS

Patient 1.
A 4-year-old boy presented to the emergency department after sustaining a closed transverse fracture of the arm. Vital signs were normal, and the patient was afebrile. After application of a long arm cast, the patient was discharged while receiving acetaminophen with codeine. Within 24 h, severe pain and swelling in the affected arm and fingers prompted his hospital admission. Intravenous cefazolin therapy was commenced, and the patient was taken to the operating room. Muscle compartment pressures were elevated, and muscles of the hand were "blackened." After a volar fasciotomy of the superficial and deep compartments of the left forearm, the arm was dressed and fixed with an external splint. Tissues samples were sent for culture. Postoperatively, the patient remained afebrile, with a blood pressure of 128/82 mm Hg, but the pulse increased to 150 beats/min. Color returned to his fingers, and the patient was able to wave them to his mother. Twelve h after surgery, the patient's pulse increased to 164 beats/min, and his blood pressure decreased to 108/60 mm Hg, but he remained afebrile. The left forearm became grossly swollen, and both lower extremities were cool. Intravenous vancomycin treatment was started. The WBC count was 31,900 cells/mm 3 (figure 1), with 77% segmented neutrophils, 6% bands, 12% lymphocytes, and 5% monocytes; the hematocrit was 42.9%, and the platelet count was 210,000 platelets/mm 3 . Gentamicin and piperacillin were administered. A second surgery revealed necrotic and foul-smelling muscle, fat, and fascia, with complete cessation of blood flow to the wrist. Tissue specimens obtained during both surgeries revealed large, grampositive rods subsequently identified as C. sordellii.
The next morning, the WBC count increased to 41,200 cells/ mm 3 (figure 1), with 45% segmented neutrophils, 7% band cells, 2% myelocytes, 1% metamyelocytes, 33% lymphocytes, and 12% monocytes. The hematocrit was 41.9%. By mid-afternoon, the boy became hemodynamically unstable, with increasing hypotension, tachycardia, metabolic acidosis, and decreased urine output. Hours later, ultrasound-guided pericardiocentesis produced 75 mL of straw-colored fluid. Refractory hypotension developed, and despite intensive efforts, the patient died.
The autopsy reported generalized soft-tissue edema and a large collection of fluid in both pleural spaces and the peritoneal cavity. Histopathologic examination of the affected arm revealed severe soft-tissue necrosis, with interstitial hemorrhage and neutrophilic infiltrates in the connective tissue. No evidence of vascular thrombosis was observed.
Patient 2. A previously healthy, 21-year-old woman sustained a third-degree vaginal laceration during delivery of her second child. The wound was sutured, and 4 days later, she developed chills, difficulty urinating, and increasingly severe perineal pain that radiated into her buttocks and right thigh. figure 1 ), with 74% segmented neutrophils, 14% bands, 8% monocytes, and 4% lymphocytes. She remained tachycardic, and the findings of auscultation of her chest were unremarkable. The perineum was bluish-gray in color, and the labia were edematous. Intravenous gentamicin and clindamycin were started. CT of the pelvis and abdomen revealed only peritoneal fluid and an enlarged uterus.
Surgical debridement and fasciotomy of the vulva were performed. Vancomycin was added to the antibiotic regimen. Postoperatively, the WBC count increased to 123,400 cells/mm 3 (figure 1), with 48% segmented neutrophils, 40% bands, 3% myelocytes, 1% metamyelocytes, 4% monocytes, and 3% lymphocytes. Nucleated RBCs were also present, and the platelet count was reduced (141,000 platelets/mm 3 ). Hypotension persisted, profound metabolic acidosis (pH 7.15) ensued, and hypomagnesemia (magnesium level, 0.9 mmol/L) and hypocalcemia (calcium level, 7.26 mmol/L) developed. Antibiotics, sodium bicarbonate, magnesium sulfate, and copious quantities of intravenous fluids were administered. Shortly after surgery, her heart rate increased to 160-170 beats/min, cardiac arrest ensued, and she died.
Bacterial culture of specimens of the debrided perineal tissue yielded heavy growth of C. sordellii and moderate growth of Clostridium perfringens, Prevotella loeschii, and additional mixed anaerobic flora. Blood culture results were negative. At autopsy, the vulva was edematous and erythematous. The pericardial space and the right and left pleural cavities contained 80, 400, and 250 mL of clear, straw-colored fluid, respectively. Microscopically, moderate vascular congestion was noted in the lungs, liver, adrenal glands, and kidneys. The myometrium was hypertrophic and hyperplastic, with fibrin thrombi in the blood vessels of the endometrium. The cervix was markedly congested with edema and chronic inflammation. Histopathologic examination of the uterine tissue revealed large, rod-shaped organisms and modest numbers of inflammatory cells in various stages of degeneration (figure 2). (table 1) . These patients, plus the 2 described here, bring the total cases for analysis to 45 (table 1) . Of the cases reviewed in which the patient's sex was specified, most (23 [63%] of 37) C. sordellii infections occurred in women with a mean age of 33.6 years (tables 1 and 2). Of these, 8 (35%) of 23 cases were associated with normal childbirth [15] [16] [17] [18] [19] 23] , 5 (22%) were associated with medically induced abortion (MIA) [20, 21] , and 2 (9%) were associated with spontaneous abortion [22] (table 1) . The mortality rate was 100%. C. sordellii was implicated in all cases, but it was the sole pathogen in only 2 of these cases. Other organisms isolated included C. perfringens, Escherichia coli, staphylococcal and streptococcal species, and a variety of other anaerobes and coliforms.
EPIDEMIOLOGY OF
The source of C. sordellii in obstetric/gynecological-associated infections is unknown, although 2 reports have documented prolonged vaginal carriage of C. sordellii in 0.5%-10% of healthy women [44, 45] , suggesting that some women may be natural C. sordellii carriers. The rate of vaginal colonization with a variety of Clostridium species during the period after childbirth or abortion is reportedly as high as 29% [46, 47] . Alternatively, fecal contamination of the vagina during vaginal delivery could provide a source of organisms that could infect vaginal tears or the episiotomy site or ascend to the uterus through the open cervix. However, no C. sordellii-related deaths have been reported following instrumented abortion or routine dilatation and curettage, both of which require opening of the cervix, perhaps because fecal contamination of the vagina in these settings is less likely.
C. sordellii infection after MIAs. Mifepristone (RU-486; Danco Laboratories) has been used worldwide as a birth control alternative. Mifepristone inhibits the action of progesterone by blocking glucocorticoid receptors and is used in conjunction with misoprostol, a synthetic prostaglandin that stimulates heavy vaginal secretion. These agents cause the uterine lining to slough, preventing implantation. Nearly 2 million women in Europe have used mifepristone, and no C. sordellii infections or deaths have been reported [45] . In addition, since the year 2000, more than 600,000 women in the United States have undergone mifepristone-induced abortion. There have been 5 reported C. sordellii-related deaths worldwide due to mifepristone-associated MIA (table 1) , and all occurred in North America. This equates to ∼1 death per 120,000 patients in North America [45] . Investigators have failed to identify any specific factor that predisposed these women to fatal infection. Interestingly, 80% of reported C. sordellii-related deaths occurred in the state of California. The regional nature of these fatalities suggested that the medication may be contaminated with C. sordellii, but this was proved not to be the case. Misuse of misoprostol-specifically, intravaginal administration-may also be to blame and is currently under investigation [48] .
The association between lethal C. sordellii infection and MIA raised concerns of mifepristone's safety. On 19 July 2005, the US Food and Drug Administration issued a public health advisory regarding C. sordellii-associated deaths involving mifepristone/misoprostol-induced MIA [49] . As with many rapidly fatal diseases, prevention is paramount. The manufacturer of mifepristone has recently provided information for patients and health care providers warning that C. sordellii infections may have unusual manifestations and that delays in treatment can result in fatal outcomes [50] . Prohibiting vaginal administration of misoprostol has also been suggested as a preventative measure [48] .
Potential pathogenic mechanisms have only recently been suggested. Mifepristone/misoprostol may facilitate colonization of uterine tissue, trigger toxin expression, or induce hypotension and systemic shock by dysregulating the host's immune response. These and other mechanisms are actively being investigated.
C. sordellii infection in injection drug users. Several studies of fatal C. sordellii soft-tissue infection in injection drug users in Europe and North America have been published [24] [25] [26] 51] . In our review, 10 (22%) of 45 reported C. sordellii infections fell into this category. Of these, 50% were fatal (table  1) . In 1999, an outbreak of necrotizing soft-tissue infection occurred in California stemming from "skin popping" of black tar heroin. C. sordellii was identified in 6 of 9 wound specimens, and 4 of 9 patients died [26] . Two similar outbreaks of infection were also reported in the San Francisco, California, area during 1992-1997 and again in 1999; C. sordellii was isolated in 4 of 9 and 2 of 5 patients, respectively [24, 51] . During 2000-2004, nearly 200 cases of soft-tissue infection in injection drug users were reported in the United Kingdom. Nearly 95% of the infections requiring hospitalization were caused by clostridial species, including C. sordellii [25] . It was postulated that the drug paraphernalia or the drugs "cut" with soil were contaminated with spores. In either case, repeated injection of drugs into the subcutaneous tissue likely resulted in local ischemia that provided an anaerobic environment favorable to the germination and outgrowth of clostridial spores.
Other C. sordellii infections. C. sordellii infections were by no means limited to gynecological procedures and illicit drug use (table 1) . In fact, 19 (42%) of 45 cases of C. sordellii infection occurred after nongynecological surgical procedures or penetrating, crush, or traumatic injuries to the soft tissues in previously healthy men, women, and children (table 1). Of these 19 patients, 10 (53%) died.
Three reports, including our own, described C. sordellii infections in children. One involved a 17-day-old infant who developed neonatal toxic omphalitis [37] and died, despite having received 6 days of aggressive treatment that included multiple debridements and broad-spectrum antibiotic therapy. Both umbilical tissue and peritoneal fluid collected at surgery grew C. sordellii; no complications were reported involving the mother. The other patient described was a 12-year-old boy who developed C. sordellii sepsis after an ear infection but survived after an intensive 2-week course of antibiotic therapy and supportive care [29] .
Numerous postsurgical C. sordellii infections have occurred after hysterectomy, musculoskeletal-tissue allograft, liver transplantation, prostate surgery, and eye surgery [32, 33, 35, 36, 52] . C. sordellii infections have also been reported after traumatic, penetrating injures to the foot and leg [28, 30] . "Spontaneous" C. sordellii infections were also reported in patients with underlying conditions, such as alcoholism with liver cirrhosis, malignancies, and immunosuppression [34, [53] [54] [55] . In these cases, patients had no obvious portals of entry, yet all developed lethal C. sordellii infections. Indeed, spontaneous infections in compromised individuals have also been reported with other clostridial species (e.g., Clostridium septicum and C. difficile). Other reported C. sordellii infections included pneumonia, empyema, septic arthritis, and endocarditis [38] [39] [40] [41] [42] [43] .
SUMMARY OF CLINICAL FEATURES OF C. SORDELLII INFECTION
Early clinical symptoms of infection include nausea, dizziness, lethargy, and mild tenderness or rash at sites of infection. Most patients (73%) were afebrile (table 3) . Within hours after presentation to the hospital, patients have developed hypotension and tachycardia. Laboratory tests have demonstrated elevated hematocrit, increased WBC and platelet counts, and decreased serum calcium and protein levels. As infections progressed, 6 distinctive clinical features developed that, in total, are unique to C. sordellii infection: a marked leukocytosis termed the "leukemoid reaction," refractory hypotension, severe tachycardia, profound capillary leak syndrome, hemoconcentration, and a persistent absence of fever. Specifically, the leukemoid reaction 200 ϫ 10 leukemoid reaction is also characteristic of C. difficile and Clostridium novyi infections [57, 58] . Differential cell counts revealed increased percentage of mature and immature neutrophils (i.e. band cells, metamyelocytes, and myelocytes) [56] and an increase in the absolute numbers of both lymphocytes and monocytes.
The markedly elevated WBC count was highly predictive of fatal outcome. On average, those who died from C. sordellii infection had a WBC count of 175,000 cells/mm 3 , compared ; however, in 2 of these patients, WBC counts were only obtained at hospital admission, and no repeated complete blood cell count data were reported; the other 2 cases were associated with unusually prolonged illnesses (3 and 5 weeks, respectively) in compromised individuals.
Along with the increasing WBC counts, severe tachycardia and tachypnea were frequently described, and subsequent peritoneal and pleural effusions were common. This capillary leak likely contributed to markedly elevated hematocrits and may have resulted from toxin-mediated changes to the vascular endothelium (see Pathogenesis). Most patients who died (19 of 26) remained afebrile throughout the disease course (tables 2 and 3), and no differences in mean temperatures were noted between survivors and nonsurvivors (37.7ЊC vs. 37.3ЊC respectively; table 2). Reasons for this lack of fever have not been investigated.
Overall, the mortality rate for patients with C. sordellii infection was nearly 69% (table 1) , and most patients died of hypotension and multiorgan failure within days to hours after the initial presentation. Postmortem findings included softtissue necrosis at the site of infection and visceral edema. On microscopic examination, infected tissues displayed acute inflammatory changes and localized thrombosis of blood vessels. Often, the margin between healthy and necrotic tissue contained heavy neutrophil degeneration. In all cases but 1, C. sordellii was identified at the site of infection, and in 9 of 45 cases, C. sordellii was found in the blood (table 1) .
PATHOGENESIS
The role of C. sordellii toxins in pathogenesis. Pathogenic strains of C. sordellii produce up to 7 identified exotoxins [1] . Of these, lethal toxin (LT) and hemorrhagic toxin (HT) are regarded as the major virulence factors. Other exotoxins include an oxygen-labile hemolysin, neuraminidase, DNase, collagenase, and lysolecithinase (table 4). The roles of these toxins in pathogenesis have not been extensively investigated.
The family of large clostridial cytotoxins. In 1969, Arseculeratne et al. [59] demonstrated that intramuscular injection of crude C. sordellii toxins into guinea pigs produced local necrosis, progressive edema, and terminal shock-symptoms similar to those found in human cases of C. sordellii infection (this review). These authors suggested that the lethal effects were the result of 2 factors: an edema-producing, lethal toxin and an extractable hemorrhagic toxin [59] .
LT and HT are members of the large clostridial cytotoxin (LCC) family [60, 61] , all members of which have molecular weights of 250-308 kDa. Other members include the C. difficile toxins A and B and C. novyi a-toxin (table 4). All LCCs possess remarkable amino acid similarity, with identities of 26%-76%. LT and C. difficile toxin B have the highest homology with amino acid sequences, being 76% identical and 90% homologous to one another.
All LCCs possess glycosyltransferase activity, utilizing UDPglucose or N-acetylglucosamine as their cosubstrate to modify members of the Rho GTPase signaling superfamily [62, 63] . These GTPases control cell cycle, apoptosis, gene transcription [64] [65] [66] , and the structural functions of actin, such as cell morphology, migration, and polarity [67, 68] . Specifically, C. difficile toxins A and B, HT from C. sordellii, and the C. novyi a-toxin UDP-glycosylate the hydroxyl group of threonine-35 in Rac, Cdc42, or Ras (or threonine-37 in Rho) [69, 70] . These critical threonine residues are found in the effector region of these signaling proteins and are highly conserved among all small GTPase molecules and in some heterotrimeric G proteins [71, 72] . The threonine targets are exposed only in the molecule's inactive GDP-bound state. Once modified, these proteins become inoperative. In the case of Rho, Rac, and Cdc42, modification impairs actin cytoskeletal assembly and organization, presumably leading to the massive capillary leakage characteristic of C. sordellii infection. LT from C. sordellii is the only LCC with unique targets, modifying Rac, Cdc42, and members of the Ras signaling family, including Ras, Ral, and Rap [73] . Interestingly, Jank et al. [74] have recently shown that change of a single amino acid residue (ser 6 phe) at position 73 converts RhoA into a substrate for LT. Furthermore, Mesmin et al. [75] demonstrated that the glucosyltransferase domain of LT binds preferentially to phosphatidylserine liposomes, suggesting that this avidity directs the toxin to the inner leaflet of the cell membrane where the targets for LT-mediated modification are abundant. A recent study by Waschke et al. [76] demonstrated significant increases in rat microvessel permeability after treatment with C. sordellii LT, suggesting that LT may also play a role in systemic capillary leak.
Two putative receptors for Toxin A from C. difficile have been suggested: galactose-b1-4-N-acetylglucosamine [77] and an unidentified glycosphingolipid [78] . Although the receptors have not been clearly identified or characterized, it is known that toxins enter host cells through an endosomal pathway [61] . The low endosomal pH generates a conformational change in the LCC structure, resulting in insertion and translocation of the toxin's enzymatic region into the cytosol [61] . Reduced pH may also trigger toxin gene expression in C. sordellii or increase the activity of C. sordellii toxins. For instance, Qa'Dan et al. [79] demonstrated that the cytotoxic activity of LT is increased 5-fold in an acidic environment (pH 4.0-5.0) in vitro. Furthermore, Voth et al. [80] have shown that LT is irreversibly dissociated into active polypeptides at low pH. Although some environments with reduced pH are frequent sites of C. sordellii infection (e.g., the normal vagina and injured tissues with inadequate perfusion), a role of pH-dependent cytotoxicity in pathogenesis remains to be verified.
Finally, although the leukemoid reaction is a remarkable clinical feature of C. sordellii infection, nothing is known regarding the underlying mechanisms. Ras GTPases control cell differentiation and proliferation [81, 82] , and by their modification, LT may play a role in the characteristic leukemoid reaction, although this has yet to be investigated. The similar leukemoid reactions in C. difficile and C. novyi infections suggest that a common toxin may be responsible.
CURRENT PERSPECTIVES ON DIAGNOSIS AND TREATMENT
Clinical clues and diagnosis. Early diagnosis of C. sordellii infection often proves to be difficult for several reasons. First is the low prevalence of these infections. Second, the initial symptoms are nonspecific and, frankly, misleading (table 3) . Early in the course, the illness resembles any number of infectious diseases, including viral syndromes. Given these vague symptoms and an absence of fever, physicians usually do not aggressively pursue additional diagnostic tests. The absence of local evidence of infection and the lack of fever makes diagnosis of C. sordellii infection particularly problematic in patients who develop deep infection after childbirth, therapeutic abortion, gastrointestinal surgery, or trauma. Such patients are frequently evaluated for pulmonary embolization, gastrointestinal bleeding, pyelonephritis, and cholecystitis. Unfortunately, such delays in diagnosis increase mortality, and as is the case in most necrotizing soft-tissue infections, by the time local signs and symptoms are apparent, patients are hypotensive, with evidence of organ dysfunction. In contrast, infection is more readily suspected in injection drug users who present with local swelling, pain, and redness at injection sites. This early recognition likely contributes to the lower mortality rate in this group.
Onset of hypotension and tachycardia prompts aggressive initiation of a variety of diagnostic procedures. Among patients with cutaneous evidence of infection, surgical intervention is essential to obtain specimens for Gram stain and culture. CTs and MRIs may reveal swelling of the affected area; however, in postpartum women, an enlarged uterus is not unusual. Gas in the tissues will not be evident unless other organisms, such as C. perfringens and Bacteroides species, are present. By the time hypotension develops, the complete blood cell count usually reveals a leukemoid reaction and the hematocrit is normal or elevated. Hypotension is persistent and refractory to even massive intravenous fluid administration. Liver function test values, such as bilirubin, alanine aminotransferase level, and alkaline phosphatase level, are usually normal, although the serum albumin decreases precipitously to levels of р1.0 g/dL. The decrease in the albumin level is clearly related to the diffuse capillary leak syndrome and parallels an increasing hematocrit. At this stage of illness, massive peripheral edema is present, and radiography demonstrates pleural and peritoneal effusions and diffuse pulmonary infiltrates. Patients with such findings develop severe respiratory failure. Persistent hypotension results in elevation of serum creatinine level, increased lactic acid level, a decreasing serum bicarbonate level, and hypoxia, necessitating intubation. Although vasopressors are frequently used in such patients, there is little to suggest they are effective.
Physicians should suspect C. sordellii infection in patients who present within 2-7 days after an injury, surgical procedure, drug injection, childbirth, or MIA and who complain of pain, nausea, vomiting, and diarrhea but are afebrile. An increasing WBC count with left shift and evidence of hemoconcentration would strongly suggest C. sordellii infection, and a definitive diagnosis should be intensively sought. Imaging studies may reveal the site of infection and thereby facilitate timely surgical intervention for debridement and obtaining diagnostic material. At present, no rapid tests exist to identify C. sordellii.
Treatment. There is little, if any, information regarding appropriate treatment for C. sordellii infection. In fact, the time between onset of symptoms and death is often so short that little time exists to initiate empirical antimicrobial therapy. Indeed, anaerobic cultures of blood and wound aspirate specimens are time consuming, and many hospital laboratories do not routinely perform antimicrobial susceptibility testing on anaerobes. Antibiotic susceptibility data from older studies suggest that C. sordellii, like most clostridia, are susceptible to blactams, clindamycin, tetracycline, and chloramphenicol but resistant to aminoglycosides and sulfonamides [83] . Potentially, antibiotics that suppress toxin synthesis (e.g., clindamycin) could be useful adjuncts to therapy, because these agents have been proven to be effective in necrotizing infections due to other toxin-producing, gram-positive organisms [84] [85] [86] . Studies to examine the efficacy of bacterial protein synthesis inhibitors in this infection should be undertaken.
Intensive care measures, including administration of intravenous fluids, are required for patients with tachycardia and hypotension. Emergency surgery to remove necrotic tissues is important for diagnosis, source control, and reducing the buildup of toxins. Use of a C. sordellii anti-toxin might also be beneficial [15, 16, 21, 26, 28, 34, 37] . Indeed, in experimental studies, antitoxins prevented both cytotoxicity in cell culture systems and lethality in a mouse model of C. sordellii toxemia [59, 87, 88] . However, no commercially available antitoxin preparation currently exists for use in humans, but it is worthy of development. Other reported treatments included the administration of steroids, morphine, atropine, and/or vasopressors, all of which have proven to be ineffective once infection was established.
SUMMARY
Renewed interest in C. sordellii pathogenesis has followed recent reports of fatal infections associated with MIAs and injection drug use. Indeed, 15 (33%) of all 45 reported cases were associated with these 2 epidemiological groups, and overall, 10 (67%) of 15 patients died. In virtually all cases, the time from onset of symptoms to death was extremely short (2-6 days), and patients invariably developed a profound systemic capillary leak, refractory hypotension, and a marked leukemoid reaction. Diagnosis is confounded by early, nonspecific signs and symptoms and by the absence of fever. Rapid diagnostic tests for C. sordellii are largely unavailable but are sorely needed. Mechanisms of pathogenesis of this infection are not clearly defined, but they likely involve potent exotoxins and, possibly, a dysregulated host immune response. The ineffectiveness of currently available treatments is exemplified by a high mortality rate (69%) and extensive morbidity. Additional research is needed to develop molecular techniques to rapidly detect and identify the organism and, potentially, its toxins and to generate novel therapeutic strategies.
